Back to Authors

Williams, Riley J.

https://orcid.org/0000-0003-2991-7173

Mayo Clinic

Hospital for Special Surgery

Citations 12

Bone Marrow Concentrate Improves Early Cartilage Phase Maturation of a Scaffold Plug in the Knee
Krych, Aaron J. , Nawabi, Danyal H. , Farshad‐Amacker, Nadja A. , Jones, Kristofer J. , Maak, Travis G. , Potter, Hollis G. , Williams, Riley J. , Krych, Aaron J

The American Journal of Sports Medicine | November 16, 2015 | Volume: 44 | Issue: 1 | Pages: 91-98

10.1177/0363546515609597 Get It

Background: Limited information exists on the clinical use of a synthetic osteochondral scaffold plug for cartilage restoration in the knee. Purpose/Hypothesis: The purpose of this study was to compare the early magnetic resonance imaging (MRI) appearance, including quantitative T2 values, between cartilage defects treated with a scaffold versus a scaffold with platelet-rich plasma (PRP) or bone marrow aspirate concentrate (BMAC). The hypothesis was that the addition of PRP or BMAC would result in an improved cartilage appearance. Study Design: Cohort study; Level of evidence, 3. Methods: Forty-six patients with full-thickness cartilage defects of the femur were surgically treated with a control scaffold (n = 11), scaffold with PRP (n = 23), or scaffold with BMAC (n = 12) and were followed prospectively. Patients underwent MRI with a qualitative assessment and quantitative T2 mapping at 12 months after surgery. An image assessment was performed retrospectively by a blinded musculoskeletal radiologist. The cartilage phase was measured by cartilage fill and quantitative T2 values on MRI. A comparison between groups after cartilage repair was performed. Results: The control scaffold group consisted of 8 male and 3 female patients (mean age, 38 years; mean body mass index [BMI], 25 kg/m 2 ), the PRP group had 15 male and 8 female patients (mean age, 39 years; mean BMI, 26 kg/m 2 ), and the BMAC group consisted of 8 male and 4 female patients (mean age, 36 years; mean BMI, 26 kg/m 2 ). The PRP-treated ( P = .002) and BMAC-treated ( P = .03) scaffolds had superior cartilage fill compared with the control group. With quantitative methods, the PRP group demonstrated a mean T2 value (49.1 ms) that was similar to that of the control scaffold group (42.7 ms; P = .07), but the BMAC group demonstrated a mean T2 value (60.5 ms) closer to that of superficial hyaline cartilage ( P = .01). The stratification of T2 values between the deep and superficial zones was not observed in any of the groups. Conclusion: In this comparative study, patients treated with scaffold implantation augmented with BMAC had improved cartilage maturation with greater fill and mean T2 values closer to that of superficial native hyaline cartilage at 12 months. Further work will determine if this translates into improved clinical outcomes.
Return to Athletic Activity After Osteochondral Allograft Transplantation in the Knee
Krych, Aaron J. , Robertson, Catherine , Group, the Cartilage Study, Williams, Riley J. , Group, the Cartilage Study, Krych, Aaron J

The American Journal of Sports Medicine | February 8, 2012 | Volume: 40 | Issue: 5 | Pages: 1053-1059

10.1177/0363546511435780 Get It

Background: Fresh-stored osteochondral allografts have been used successfully to resurface large chondral and osteochondral defects of the knee. However, there are limited data available for the return to athletic activity. Purpose: To review the rate of return to athletic activity after osteochondral allograft transplantation in the knee and to identify any potential risk factors for not returning to sport. Study Design: Case series; Level of evidence, 4. Methods: Forty-three athletes were treated with fresh-stored osteochondral allograft transplantation for symptomatic large chondral or osteochondral defects of the knee from 2000 to 2010. The average age of the athletes (30 men, 13 women) was 32.9 years (range, 18-49 years). Patients were prospectively evaluated by International Knee Documentation Committee (IKDC), activities of daily living scale of the Knee Injury and Osteoarthritis Outcome Score (KOOS), Marx Activity Rating Scale, and Cincinnati Sports Activity Scale scores. A multivariable regression analysis was performed to identify potential risk factors for failure to return to sport at the preinjury level. Results: At an average 2.5-year follow-up, limited return to sport was possible in 38 of 43 athletes (88%), with full return to the preinjury level achieved in 34 of 43 athletes (79%). In these 34 athletes, time to return to sport was 9.6 ± 3.0 months. Age ≥25 years ( P = .04) and preoperative duration of symptoms greater than 12 months (odds ratio, 37; P = .003) negatively affected the ability to return to sport. In the athletes who returned to their previous level of competition, IKDC ( P < .001), KOOS ( P = .02), and Marx Activity Rating Scale ( P < .001) scores were all significantly greater than in those athletes who did not return to sport. Conclusion: Osteochondral allograft transplantation in an athletic population for chondral and osteochondral defects in the knee allows for a high rate of return to sport. Risk factors for not returning to sport included age ≥25 years and preoperative duration of symptoms ≥12 months.